Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ana Carolina Branco Neves Silva"'
Autor:
Leandro Jonata de Carvalho Oliveira, Amanda Muniz Rodrigues, Carolina de Bustamante Fernandes, Fernanda Orpinelli Ramos do Rego, Fernanda Christtanini Koyama, Andreza Karine de Barros Almeida Souto, Thaiana Aragão Santana, João Paulo Gonzaga de Faria, Marcela Lima Bulcão, Ivana Lucia de Oliveira Nascimento, Ana Carolina Branco Neves Silva, Isabela Pessoa Elias Gonçalves, Rayana Elias Maia, Renata Gondim Meira Velame de Azevedo, Layla Testa Galindo, Daniela Vianna Pachito, Adriana Cury, Mariano Gustavo Zalis, Bruno Lemos Ferrari, Bernardo Garicochea, Rodrigo Dienstmann
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionThe prevalence of germline pathogenic/likely pathogenic variants (P/LP) in high and moderate penetrance (HMP) genes is approximately 7%–10% among breast cancer (BC) patients. The prevalence and spectrum of BC P/LP variants are affected
Externí odkaz:
https://doaj.org/article/150f3409ddf44abc8817bbe6c52a0d6d
Autor:
Thiago Alexandre Martins Marques, Ana Carolina Branco Neves Silva, Marconi Roberto Lemos Meira, Mariana de Albuquerque Borges, Raquel Nogueira Cordeiro, Diego Laurentino Lima
Publikováno v:
International Journal of Surgery Science. 4:299-302
During the diagnosis of the primary CRC, about 20% of patients have already developed metastatic diseases, and the most commons metastatic sites include the liver and lungs. Bone metastasis (BM) is rare and is reported only in 10–15% of patients wi
Autor:
Bernardo Garicochea, Fernanda Christtanini Koyama, Amanda Canato Ferracini, Carolina de Bustamante Fernandes, Andreza Karine Souto, Marcela Lima Bulcao, Ivana Lucia de Oliveira Nascimento, Ana Carolina Branco Neves Silva, Luciana G. Landeiro, Leandro Carvalho Oliveira, Alessandra Starling, Isabela Pessoa Elias Gonçalves, Rayana Elias Maia, Thaiana Aragão Santana, Layla Testa Galindo, Mariano Zalis, Bruno Lemos Ferrari, Rodrigo Dienstmann
Publikováno v:
Journal of Clinical Oncology. 40:10594-10594
10594 Background: As germline testing in BC is becoming more accessible, a large body of evidence from distinct populations is revealing different prevalence of affected genes or recurrent and founder mutations. We evaluated a series of Brazilian BC